Skip to main content

DIADEMA PARTNERS LP

Position in JAZZ — Jazz Pharmaceuticals plc

CIK 2026172 MORRISTOWN, NJ

Position in JAZZ

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$10,351,432
+$10,351,432 QoQ
Shares Held
54,755
Ownership
0.087%
of shares outstanding
% of Portfolio
4.62%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in JAZZ Over Time

Shares Held

Position Value (USD)

Derivatives in JAZZ

reported options exposure · as of Dec 31, 2025
CallValue
$17,901,000
CallShares
105,300
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

DIADEMA PARTNERS LP holds $176,357,038 across 73 Biotechnology names. JAZZ ranks #3 (5.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 JAZZ
Jazz Pharmaceuticals plc
This page
54,755 $10,351,432

All Filings in JAZZ

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $10,351,432 54,755
2025-12-31 $17,901,000 105,300
2025-09-30 $6,590,000 50,000
2025-09-30 $3,049,852 23,140
2025-09-30 $13,180,000 100,000
2025-06-30 $5,306,000 50,000
2025-06-30 $11,086,674 104,473
2025-03-31 $12,415 100
2025-03-31 $8,789,820 70,800
2025-03-31 $10,824,514 87,189
2024-12-31 $1,812,644 14,719